Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-02-05

Clinical Trial Update: Effect of Lofexidine and Oral THC on Marijuana Withdrawal and Relapse [Phase 2]

View source ↗

Summary

This Phase 2 trial assessed the effects of lofexidine and oral tetrahydrocannabinol on marijuana withdrawal and relapse in cannabis use disorder, and the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dronabinol (dronabinol)
  • LOFEXIDINE (LOFEXIDINE)

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Marijuana Dependence | Phase 2 | Status: COMPLETED